Prevention & lipidsSecondary analysis
Small-Interfering RNA Olpasiran and Apolipoprotein B Particles
- Secondary analysis of the OCEAN(a)-DOSE randomised trial
Study context
- Primary endpoint
- Effect of olpasiran on atherogenic lipoproteins
Original publication
Small-Interfering RNA Olpasiran and Apolipoprotein B Particles. JAMA Cardiol. Published 1 December 2025. doi:10.1001/jamacardio.2025.4105
Summarised from the published abstract; every number is checked against it